JonathanReedWhisenantMD

PubMed

• A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembroliz...
  Matthew Gumbleton, Stephanie Allan, Hannah Conway, Kenneth Boucher, James Marvin, Josiah Hawks, William Burnett, Matthew Van Brocklin, Jonathan Whisenant, Glynn Gilcre...> ;BMC Research Notes. 2023 Feb 16
• 6 citations
  Discrepancies between tumor genomic profiling and germline genetic testing.
  K Pauley, C Koptiuch, S Greenberg, W Kohlmann, J Jeter, S Colonna, T Werner, C Kinsey, G Gilcrease, J Weis, J Whisenant, V Florou, I Garrido-Laguna> ;ESMO Open. 2022 Aug 1
• 152 citations
  Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
  Andrew X. Zhu, Teresa Macarulla, Milind Javle, R. Kate Kelley, Sam J. Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, W...> ;JAMA Oncology. 2021 Nov 1
• 17 citations
  Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib.
  Vaia Florou, Christopher Nevala-Plagemann, Jonathan Whisenant, Patricia Maeda, Glynn Weldon Gilcrease, Ignacio Garrido-Laguna> ;Journal of the National Comprehensive Cancer Network. 2021 May 2
• 2 citations
  Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters using the Modified RAND/UCLA Delphi Process
  Renuka Iyer, Susan Acquisto, John Bridgewater, Michael A. Choti, Theodore S. Hong, Bela Kis, Peter A. Mead, Neehar D. Parikh, Lewis R. Roberts, Rebecca Roberts, Riad S...> ;Cancers. 2020 Aug 21
• 452 citations
  Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
  Ghassan K. Abou-Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam J. Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Brid...> ;The Lancet. Oncology. 2020 Jun 1
• 15 citations
  Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer
  G. Weldon Gilcrease, David D. Stenehjem, Mark Wade, John R. Weis, Kimberly McGregor, Jonathan Whisenant, Kenneth M. Boucher, Kelli M. Thorne, Nicole Orgain, Ignacio Ga...> ;Investigational New Drugs. 2019 Jun 15
• 18 citations
  Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
  Conan G. Kinsey, Soledad A. Camolotto, Amelie M. Boespflug, Katrin P. Guillen, Mona Foth, Amanda Truong, Sophia S. Schuman, Jill E. Shea, Michael T. Seipp, Jeffrey T. ...> ;Nature Medicine. 2019 May 1
• 408 citations
  Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
  Conan G. Kinsey, Soledad A. Camolotto, Amelie M. Boespflug, Katrin P. Guillen, Mona Foth, Amanda Truong, Sophia S. Schuman, Jill E. Shea, Michael T. Seipp, Jeffrey T. ...> ;Nature Medicine. 2019 Mar 4
• 11 citations
  Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
  Christopher Nevala-Plagemann, Samual Francis, Courtney C. Cavalieri, Randa Tao, Jonathan Whisenant, Robert E. Glasgow, Courtney L. Scaife, Shane Lloyd, Ignacio Garrido...> ;ESMO Open. 2018 Jul 1
• 246 citations
  Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines
  Manisha H. Shah, Whitney S. Goldner, Thorvardur R. Halfdanarson, Emily K. Bergsland, Jordan Berlin, Daniel M. Halperin, Jennifer A. Chan, Matthew H. Kulke, Al B. Benso...> ;Journal of the National Comprehensive Cancer Network. 2018 Jun 1
• 17 citations
  Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis
  Anna Torgeson, Shane Lloyd, Dustin Boothe, George Cannon, Ignacio Garrido-Laguna, Jonathan Whisenant, Mark A. Lewis, Robin D. Kim, Courtney L. Scaife, Randa Tao> ;Annals of Surgical Oncology. 2017 Oct 17
• 31 citations
  Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
  Anna Torgeson, Shane Lloyd, Dustin Boothe, Randa Tao, Jonathan Whisenant, Ignacio Garrido-Laguna, George Cannon> ;Cancer. 2017 Oct 1
• 7 citations
  Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus.
  Hilary P. Bagshaw, William T. Sause, Ute Gawlick, H. Tae Kim, Jonathan Whisenant, George M. Cannon> ;American Journal of Clinical Oncology. 2016 Jul 19
• 4 citations
  N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012.
  Ignacio Garrido-Laguna, Danielle Tometich, Nan Hu, Jian Ying, Katherine B. Geiersbach, Jonathan Whisenant, Kai Wang, Jeffrey S. Ross, Sunil Sharma> ;Oncoscience. 2015 Mar 14
• 13 citations
  Anti-angiogenic strategies in gastrointestinal malignancies.
  Jonathan Whisenant, Emily K. Bergsland> ;Current Treatment Options in Oncology. 2005 Sep 1
• Regional therapy of liver metastases.
  Jonathan Whisenant, Alan P. Venook> ;Current Treatment Options in Oncology. 2004 Oct 1
• 3 citations
  Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer.
  Jonathan Whisenant, Alan P. Venook> ;Oncology. 2004 May 1
• Join now to see all